IMCD NV/ NL0010801007 /
20/12/2024 17:36:15 | Chg. +0.88 | Volume | Bid17:36:15 | Demandez à17:36:15 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
140.78EUR | +0.63% | 58,287 Chiffrre d'affaires: 3.59 Mio. |
-Bid taille: - | -Ask la taille: - | 8 Mrd.EUR | 1.59% | 27.40 |
GlobeNewswire
02/03/2022
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Ac...
GlobeNewswire
16/02/2022
Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melano...
GlobeNewswire
18/03/2020
Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study
GlobeNewswire
13/01/2020
EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® ...
GlobeNewswire
28/02/2019
Adhesives - Global Market Analysis, Trends and Forecasts 2019: Outsourcing of Manufacturing Activity...
GlobeNewswire
16/11/2018
Asia Pacific Biopharma Excipients (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates, S...
GlobeNewswire
26/09/2018
IMCD completes acquisition of European speciality chemicals distributor Velox
GlobeNewswire
01/08/2018
IMCD completes acquisition of US specialty chemicals distributor E.T. Horn Company
GlobeNewswire
05/03/2018
Nutraceutical Excipients Market Poised to Register 7.3% CAGR through 2026, globally - Future Market ...
GlobeNewswire
02/03/2018
IMCD to nominate Management Board and Supervisory Board members for (re)appointment
GlobeNewswire
08/02/2018
Adhesives Markets 2016-2024 by Volume & Value - Global Strategic Business Report 2017
GlobeNewswire
04/08/2017
IMCD to acquire the Canadian and US specialty chemicals and ingredients distributor L.V. Lomas
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page